BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/11/2022 6:48:54 AM | Browse: 518 | Download: 1007
 |
Received |
|
2021-04-20 09:14 |
 |
Peer-Review Started |
|
2021-04-20 09:16 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-06-05 02:36 |
 |
Revised |
|
2021-06-30 20:12 |
 |
Second Decision |
|
2021-12-24 04:48 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-12-25 20:13 |
 |
Articles in Press |
|
2021-12-25 20:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2022-01-05 13:06 |
 |
Publish the Manuscript Online |
|
2022-01-11 06:48 |
Category |
Endocrinology & Metabolism |
Manuscript Type |
Review |
Article Title |
Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review
|
Manuscript Source |
Invited Manuscript |
All Author List |
Sarantis Livadas, Panagiotis Anagnostis, Julia K Bosdou, Dimitra Bantouna and Rodis Paparodis |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Sarantis Livadas, MD, PhD, Consultant Physician-Scientist, Endocrine Unit, Athens Medical Centre, M. Geroulanou 15, Athens 10563, Greece. sarntis@gmail.com |
Key Words |
polycystic ovary syndrome; PCOS; diabetes; insulin resistance; dysglycemia |
Core Tip |
Polycystic ovary syndrome (PCOS) often coexists with a wide spectrum of dysglycemic conditions, ranging from impaired glucose tolerance to type 2 diabetes mellitus (T2D), which occur to a greater extent compared to healthy body mass index-matched women. This review provides the most current knowledge on the different aspects of T2D in women with PCOS, including epidemiology, common pathophysiologic mechanisms, and methodology employed for dysglycemia assessment, as well as to scrutinize the risk factors for T2D development and to suggests the optimal management of these women in the context of T2D risk reduction. |
Publish Date |
2022-01-11 06:48 |
Citation |
Doğruel H, Aydemir M, Balci MK. Management of diabetic foot ulcers and the challenging points: An endocrine view. World J Diabetes 2022; 13(1): 5-26 |
URL |
https://www.wjgnet.com/1948-9358/full/v13/i1/5.htm |
DOI |
https://dx.doi.org/10.4239/wjd.v13.i1.5 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345